Public consultation on the control of surgical instruments and appliances draft regulations 2018
Thursday, 10th May 2018
The National Drug Authority Invites feedback from the distributors and healthcare professionals as well as consumers and the general public on the proposed control of surgical Instruments and appliances draft regulations. A copy of the draft regulation is available at this Link. All feedback should be sent to email@example.com by 30th May 2018.
Section 64 (g) provides for making regulations for better carrying into effect the provisions of the act –regulate, restrict or prohibit importation ,sale or advertising of surgical instruments and appliances. NDA working in collaboration with stakeholders over the past few years has been laying the foundation for the launch of a regulatory framework for surgical instruments and appliances.
NDA has drawn up a proposed regulation of surgical instruments and appliances and now seeks input and views from distributors, healthcare professionals as well as consumers, and general public to further improve and refine the regulation before it is formalized.
In drafting the regulation, NDA has considered a measured approach to safeguard public health without restricting access to essential and new technologies.
Controls for Import, Sale and Advertising of Surgical Instruments and appliances
The proposed framework comprises of the following key fundamentals:
The licensing controls are aimed at regulating the supply chain and ensuring that only bona fide persons are engaged in dealing with surgical instruments and appliances.
Control on advertising
NDA sets out circumstances under which advertising and promotion is permitted to curb any false or misleading advertising claims inconsistent with safety, quality and intended use of the products as registered.
All surgical instruments and appliances shall be registered before sale or distribution in Uganda
Unregistered surgical instruments and appliances
Access to unregistered surgical instruments and appliances is provided for under emergency situations.
The proposed regulatory framework remains a work in progress and NDA welcomes any input or feedback from all stakeholders.
The draft regulations are subject to changes depending on the outcome of this consultation
National Drug Authority